IDEXX Laboratories, Inc. vs Global X Defense Tech ETF — how do they compare? IDEXX Laboratories, Inc. trades at $560 (market cap $44.48B), while Global X Defense Tech ETF trades at $60.3. Which is the better fit depends on your goals.
| IDXX | SHLD | |
|---|---|---|
Market Cap | $44.48B | — |
Sector | Health | Sector/Thematic |
52-Week High | $766.68 | $78.02 |
52-Week Low | $520.87 | $58.20 |
Enterprise Value | $45.38B | — |
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
SHLD trades at $60.03, down 0.05% on the day, with technical indicators showing a bearish trend from moving averages but neutral oscillators. The ETF focuses on global defense technology, benefiting from rising military budgets and geopolitical tensions. Recent news highlights institutional interest, including Decker Wealth Management's new position in Q1 2026, and analyst discussions on defense ETF comparisons amid sector tailwinds.
The outlook for SHLD is supported by structural growth in defense spending, but risks include political uncertainty and valuation concerns. Investors gain diversified exposure to defense tech innovation, though competition from other ETFs and expense ratios may impact relative performance. Near-term price action hinges on technical support at $59 and broader market sentiment toward defense stocks.
Trailing returns across standard periods
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →